BiotechTube
Home/NaDeNo/Ýrr Mørch
ÝM

Ýrr Mørch

Chief Technology Officer and Co-founder

NaDeNo

Therapeutic Areas

Oncology

NaDeNo Pipeline

DrugIndicationPhase
PACAB-002Peritoneal micrometastases in High-Grade Serous Ovarian CancerPre-clinical

Leadership Team at NaDeNo

AF
Annbjørg Falck
Chief Executive Officer and Co-founder
View full NaDeNo profile